Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety
- 75 Downloads
A new series of N-modified analogues of the VV-hemorphin-5 with aminophosphonate moiety have been synthesized, characterized and investigated for anticonvulsant activity. The novel peptide analogues were prepared by solid-phase peptide synthesis–Fmoc-strategy and were evaluated in the timed intravenous pentylenetetrazole infusion test (ivPTZ) and 6-Hz psychomotor seizure test in mice. The acute neurological toxicity was determined using the rotarod test. The redox potentials at glass carbonic electrode (GC) and the acid/base properties as pKa values of these peptide analogues were compared with the electrochemical behaviour of tyrosine- and tryptophan-containing peptides using different voltamperometric modes. Among the five tested peptide analogues, V3p was the most active against the ivPTZ test with effect comparable to that of the VV-hemorphin-5 (V1) used as a positive control. Dose-dependent elevation of the seizure threshold for myoclonic twitch and generalized clonic seizures was observed after i.c.v. administration of V2p, V4p and V5p as well as for forelimbs tonus in V4p peptides. The peptide analogues V2p–V5p were able to suppress dose-dependent psychomotor seizures in the 6-Hz test. In contrast, the V6p peptide showed either a pro-convulsant effect in the iv PTZ test or was inactive in the 6-Hz test. No changes in motor coordination were noted with the novel peptides. Docking study results suggest that kappa opioid receptor binding could be the mechanism of action of peptide derivatives with anticonvulsant activity. The results suggest that incorporation of aminophosphonate moiety at position 1 of the VV-hemorphin-5 scaffold deserve further evaluation in models of epilepsy and derivatization.
KeywordsHemorphin analogues SPPS Aminophosphonates Anticonvulsant activity Molecular docking Electrochemistry
This work was financially supported by the Bulgarian National Scientific Fund project КП-06-OПP 03/3 of the Ministry of Education and Science, Bulgaria.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures were performed in agreement with the European Communities Council Directive 2010/63/EU. The experimental design was approved by the Institutional Ethics Committee. There are no human participants.
- Che T, Majumdar S, Zaidi SA, Ondachi P, McCorvy JD, Wang S, Mosier PD, Uprety R, Vardy E, Krumm BE, Han GW, Lee MY, Pardon E, Steyaert J, Huang XP, Strachan RT, Tribo AR, Pasternak GW, Carroll FI, Stevens RC, Cherezov V, Katritch V, Wacker D, Roth BL (2018) Structure of the nanobody-stabilized active state of the kappa opioid receptor. Cell 172:55–67PubMedPubMedCentralGoogle Scholar
- Cunningham E, Drag M, Kafarski P, Bell A (2008) Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors. Antimicrob Agent Chemother 52:3221–3228Google Scholar
- Erchegyi J, Kastin AJ, Zadina JE, Qiu XD (1992) Isolation of a heptapeptide Val-Val-Tyr- Pro-Trp-Thr-Gln (valorphin) with some opiate activity. Int J Pept Prot Res 39:477–484Google Scholar
- Glämsta EL, Marklund A, Hellman U, Wernstedt C, Terenius L, Nyberg F (1991) Isolation and characterization of a haemoglobin-derived opioid peptide from the human pituitary gland. Regul Peptides 34:169–179Google Scholar
- Glämsta EL, Morkrid L, Lantz I, Nyberg F (1993) Concomitant increase in blood plasma levels of immunoreactive hemorphin-7 and beta-endorphin following long distance running. Regul Peptides 49:9–18Google Scholar
- Kafarski P, Lejczak B (2000a) Synthesis of phosphono- and phosphinopeptides. In: Kukhar VP, Hudson HR (eds) Aminophosphonic and aminophosphinic acids chemistry and biological activity. Wiley, Chichester, pp 173–204Google Scholar
- Kafarski P, Lejczak B (2000b) The biological activity of phosphono- and phosphinopeptides. In: Kukhar VP, Hudson HR (eds) Aminophosphonic and aminophosphinic acids: chemistry and biological activity. Wiley, Chichester, pp 407–442Google Scholar
- Kukhar V, Hudson H (2000) Aminophosphonic and aminophosphinic acids. Wiley, New York, pp 173–203Google Scholar
- Kukhar VP, Soloshonok VA, Solodenko VA (1994) Asymmetric synthesis of phosphorus analogs of amino acids. Phosphorus Sulfur Silicon Relat Elem 92:239–264Google Scholar
- MacDonald SM, Roscoe SG (1997) Electrochemical oxidation reactions of tyrosine, tryptophan and related dipeptides. Electrochim Acta 42(8):1189–1200Google Scholar
- Pedro P, Fernando M (1983) Phosphono-methyl amino acid(s) and ester(s). ES8506321A3Google Scholar
- Pogozheva ID, Przydzial MJ, Mosberg HI (2005) Homology modelling of opioid receptor-ligand complexes using experimental constraints. AAPS J 7:434–448Google Scholar
- Sandeman R, Chandler D, Duncan A, Hay P (2007) Insecticide and method of controlling insects. US7217831Google Scholar
- Shuvalov MV, Maklakova SY, Rudakova EV, Kovaleva NV, Makhaeva GF, Podrugina TA (2018) New Possibilities of the Kabachnik–Fields and Pudovik reactions in the phthalocyanine-catalyzed syntheses of α-aminophosphonic and α-aminophosphinic acid derivatives. Russ J Gen Chem 88:1761–1775Google Scholar
- Soloshonok VA, Sorochinsky AE (2010) Practical methods for the synthesis of symmetrically α, α-disubstituted α-amino acids. Synthesis 14:2319–2344Google Scholar
- Soloshonok VA, Belokon YN, Kuzmina NA, Maleev VI, Svistunova NY, Solodenko VA, Kukhar VP (1992) Asymmetric synthesis of phosphorus analogs of dicarboxylic alfa-amino acids. J Chem Soc Perkin Trans 1:1525–1529Google Scholar
- Tchekalarova JD, Georgiev VP (1999) Adenosine–angiotensin II interactions in pentylenetetrazol seizure threshold in mice. J Physiol 93:191–197Google Scholar
- Voet D, Voet J (1995) Biochemistry, 2nd edn. Wiley and Son, New YorkGoogle Scholar
- Xu JX, Yu L (1999) Synthesis of aminophosphonic acids and their esters. Chin J Syn Chem (Hecheng Huaxue) 7:153–158Google Scholar
- Yashchuk VM, Kudrya VYu, Levchenko SM, Tkachuk ZYu, Hovorun DM, Mel’nik VI, Vorob’yov VP, Klishevich GV (2011) Optical response of the polynucleotides–proteins interaction. Mol Cryst Liq Cryst 535:93–110Google Scholar